Skip to main content
. Author manuscript; available in PMC: 2024 Oct 10.
Published in final edited form as: Circulation. 2023 Sep 8;148(15):1165–1178. doi: 10.1161/CIRCULATIONAHA.123.064170

Figure 1. Characterization of clonal hematopoiesis in the Alberta HEART patient cohort.

Figure 1.

A. Abundance of the specified driver gene mutation in the patient cohort (n=58). B. Proportion of patients with the specified number of CH mutations (n=47). C. CH prevalence as a function of age in the patient cohort (n=117). D. VAF for the largest clone identified in patients with CH in control individuals and HFpEF patients. Statistical significance was determined by Mann-Whitney U test (n= 11 control individuals and 36 HFpEF patients). E. Prevalence of CH and driver gene mutations in control individuals and patients with HFpEF. Statistical significance was determined by Fisher’s Exact Test (n= 36 control individuals and 81 HFpEF patients).